Balchem Corp (BCPC)

$180.31

+2.28

(+1.28%)▲

Market is closed - opens 8 PM, 22 Nov 2024

Performance

  • $178.49
    $180.39
    $180.31
    downward going graph

    1.01%

    Downside

    Day's Volatility :1.05%

    Upside

    0.04%

    downward going graph
  • $120.81
    $186.03
    $180.31
    downward going graph

    33.0%

    Downside

    52 Weeks Volatility :35.06%

    Upside

    3.07%

    downward going graph

Returns

PeriodBalchem CorpSector (Materials)Index (Russel 2000)
3 Months
7.44%
2.2%
0.0%
6 Months
16.18%
2.4%
0.0%
1 Year
48.28%
15.8%
0.0%
3 Years
4.53%
5.8%
-24.1%

Highlights

Market Capitalization
5.8B
Book Value
$36.21
Dividend Share
0.79
Dividend Yield
0.44%
Earnings Per Share (EPS)
3.74
PE Ratio
47.6
PEG Ratio
4.79
Wall Street Target Price
190.333
Profit Margin
12.9%
Operating Margin TTM
20.22%
Return On Assets TTM
6.42%
Return On Equity TTM
11.04%
Revenue TTM
942.4M
Revenue Per Share TTM
29.21
Quarterly Revenue Growth YOY
4.3%
Gross Profit TTM
280.5M
EBITDA
215.1M
Diluted Eps TTM
3.74
Quarterly Earnings Growth YOY
0.14
EPS Estimate Current Year
4.36
EPS Estimate Next Year
4.89
EPS Estimate Current Quarter
1.11
EPS Estimate Next Quarter
1.14

Analyst Recommendation

Buy
    87%Buy
    12%Hold
    0
    0%Sell
Based on 8 Wall street analysts offering stock ratings for Balchem Corp(by analysts ranked 0 to 5 stars)
Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 5.56%

Current $180.31
Target $190.33

Company Financials

FY18Y/Y Change
Revenue
643.7M
↑ 8.22%
Net Income
78.6M
↓ 12.77%
Net Profit Margin
12.21%
↓ 2.93%
FY19Y/Y Change
Revenue
643.7M
↑ 0.0%
Net Income
79.7M
↑ 1.4%
Net Profit Margin
12.38%
↑ 0.17%
FY20Y/Y Change
Revenue
703.6M
↑ 9.31%
Net Income
84.6M
↑ 6.22%
Net Profit Margin
12.03%
↓ 0.35%
FY21Y/Y Change
Revenue
799.0M
↑ 13.56%
Net Income
96.1M
↑ 13.57%
Net Profit Margin
12.03%
↑ 0.0%
FY22Y/Y Change
Revenue
942.4M
↑ 17.94%
Net Income
105.4M
↑ 9.64%
Net Profit Margin
11.18%
↓ 0.85%
FY23Y/Y Change
Revenue
922.4M
↓ 2.11%
Net Income
108.5M
↑ 3.01%
Net Profit Margin
11.77%
↑ 0.59%
Q2 FY23Q/Q Change
Revenue
231.3M
↓ 0.55%
Net Income
30.1M
↑ 32.58%
Net Profit Margin
13.02%
↑ 3.25%
Q3 FY23Q/Q Change
Revenue
229.9M
↓ 0.56%
Net Income
29.1M
↓ 3.44%
Net Profit Margin
12.64%
↓ 0.38%
Q4 FY23Q/Q Change
Revenue
228.7M
↓ 0.54%
Net Income
26.6M
↓ 8.35%
Net Profit Margin
11.65%
↓ 0.99%
Q1 FY24Q/Q Change
Revenue
239.7M
↑ 4.79%
Net Income
29.0M
↑ 8.77%
Net Profit Margin
12.09%
↑ 0.44%
Q2 FY24Q/Q Change
Revenue
234.1M
↓ 2.33%
Net Income
32.1M
↑ 10.64%
Net Profit Margin
13.7%
↑ 1.61%
Q3 FY24Q/Q Change
Revenue
239.9M
↑ 2.5%
Net Income
33.8M
↑ 5.51%
Net Profit Margin
14.1%
↑ 0.4%
FY18Y/Y Change
Total Assets
981.4M
↑ 1.84%
Total Liabilities
289.7M
↓ 16.44%
FY19Y/Y Change
Total Assets
1.2B
↑ 17.76%
Total Liabilities
412.0M
↑ 42.2%
FY20Y/Y Change
Total Assets
1.2B
↑ 0.88%
Total Liabilities
337.6M
↓ 18.06%
FY21Y/Y Change
Total Assets
1.2B
↑ 2.87%
Total Liabilities
322.3M
↓ 4.53%
FY22Y/Y Change
Total Assets
1.6B
↑ 35.45%
Total Liabilities
686.2M
↑ 112.91%
FY23Y/Y Change
Total Assets
1.6B
↓ 1.68%
Total Liabilities
543.2M
↓ 20.84%
Q2 FY23Q/Q Change
Total Assets
1.6B
↓ 0.59%
Total Liabilities
612.3M
↓ 6.56%
Q3 FY23Q/Q Change
Total Assets
1.6B
↓ 0.97%
Total Liabilities
578.2M
↓ 5.57%
Q4 FY23Q/Q Change
Total Assets
1.6B
↑ 1.35%
Total Liabilities
571.2M
↓ 1.22%
Q1 FY24Q/Q Change
Total Assets
1.6B
↓ 2.24%
Total Liabilities
509.9M
↓ 10.72%
Q2 FY24Q/Q Change
Total Assets
1.6B
↓ 0.86%
Total Liabilities
462.6M
↓ 9.28%
Q3 FY24Q/Q Change
Total Assets
1.6B
↑ 1.4%
Total Liabilities
419.7M
↓ 9.27%
FY18Y/Y Change
Operating Cash Flow
118.7M
↑ 7.3%
Investing Cash Flow
-32.0M
↓ 25.07%
Financing Cash Flow
-71.4M
↑ 4.11%
FY19Y/Y Change
Operating Cash Flow
124.5M
↑ 4.86%
Investing Cash Flow
-156.2M
↑ 388.34%
Financing Cash Flow
43.4M
↓ 160.72%
FY20Y/Y Change
Operating Cash Flow
150.5M
↑ 20.92%
Investing Cash Flow
-34.6M
↓ 77.86%
Financing Cash Flow
-101.2M
↓ 333.18%
FY21Y/Y Change
Operating Cash Flow
160.5M
↑ 6.66%
Investing Cash Flow
-35.3M
↑ 2.05%
Financing Cash Flow
-102.2M
↑ 1.0%
FY22Y/Y Change
Operating Cash Flow
138.5M
↓ 13.69%
Investing Cash Flow
-416.0M
↑ 1078.51%
Financing Cash Flow
246.7M
↓ 341.42%
Q2 FY23Q/Q Change
Operating Cash Flow
35.0M
↑ 0.44%
Investing Cash Flow
-3.6M
↓ 64.11%
Financing Cash Flow
-24.8M
↓ 25.69%

Technicals Summary

Sell

Neutral

Buy

Balchem Corp is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Balchem Corp
Balchem Corp
7.58%
16.18%
48.28%
4.53%
82.91%
Air Products & Chemicals Inc.
Air Products & Chemicals Inc.
-0.45%
24.27%
19.91%
10.54%
38.42%
Linde Plc
Linde Plc
-5.58%
4.66%
10.56%
38.01%
122.08%
Dupont De Nemours Inc
Dupont De Nemours Inc
-2.52%
5.35%
16.04%
4.46%
25.7%
Sherwin-williams Company, The
Sherwin-williams Company, The
6.07%
24.77%
39.57%
16.22%
100.05%
Ecolab Inc.
Ecolab Inc.
-5.74%
4.16%
30.42%
3.79%
33.37%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Balchem Corp
Balchem Corp
47.6
47.6
4.79
4.36
0.11
0.06
0.0
36.21
Air Products & Chemicals Inc.
Air Products & Chemicals Inc.
19.08
19.08
11.78
12.33
0.23
0.05
0.02
76.53
Linde Plc
Linde Plc
33.67
33.67
2.52
15.48
0.16
0.07
0.01
82.27
Dupont De Nemours Inc
Dupont De Nemours Inc
63.95
63.95
0.45
3.9
0.02
0.03
0.02
57.94
Sherwin-williams Company, The
Sherwin-williams Company, The
36.98
36.98
3.46
11.35
0.64
0.1
0.01
16.59
Ecolab Inc.
Ecolab Inc.
34.35
34.35
2.47
6.65
0.25
0.07
0.01
23.46
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Balchem Corp
Balchem Corp
Buy
$5.8B
82.91%
47.6
12.9%
Air Products & Chemicals Inc.
Air Products & Chemicals Inc.
Buy
$73.1B
38.42%
19.08
31.64%
Linde Plc
Linde Plc
Buy
$214.3B
122.08%
33.67
19.33%
Dupont De Nemours Inc
Dupont De Nemours Inc
Buy
$34.2B
25.7%
63.95
6.55%
Sherwin-williams Company, The
Sherwin-williams Company, The
Buy
$93.6B
100.05%
36.98
11.09%
Ecolab Inc.
Ecolab Inc.
Hold
$69.4B
33.37%
34.35
13.05%

Insights on Balchem Corp

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 234.08M → 239.94M (in $), with an average increase of 2.4% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 4 quarters, 26.64M → 33.83M (in $), with an average increase of 7.6% per quarter

  • Vs LIN

    In the last 3 years, Linde Plc has given 16.2% return, outperforming this stock by 11.7%

Institutional Holdings

  • BlackRock Inc

    15.09%

  • Vanguard Group Inc

    12.06%

  • Apg All Pensions Group

    9.25%

  • Wasatch Advisors LP

    5.16%

  • Morgan Stanley - Brokerage Accounts

    4.33%

  • State Street Corp

    3.76%

Corporate Announcements

  • Balchem Corp Dividends June,2023

    In the quarter ending June,2023. Balchem Corp has declared dividend of $0.79

    Read More

Company Information

founded in 1967, balchem provides state-of-the-art solutions and the finest quality products for a range of industries worldwide. our company consists of four business segments: human nutrition & health; specialty products; animal nutrition and health and industrial products. balchem employs approximately 1,000 people worldwide who are engaged in many diverse activities, developing our company into chosen market leadership positions. visit our website at www.balchem.com to learn more about us and the exciting opportunities we have available!

Organization
Balchem Corp
Employees
1300
CEO
Mr. Theodore L. Harris
Industry
Process Industries

FAQs